According to GuruFocus Insider Data, the recent chief financial officer buys were Mayville Engineering Co. Inc. (MEC, Financial), Verb Technology Co Inc. (VERB, Financial) and TFF Pharmaceuticals Inc. (TFFP, Financial).
Mayville Engineering CFO bought 10,000 shares
CFO Todd M. Butz bought 10,000 shares for $8.75 per share on Oct. 30. Since then, the stock has gained 15.89%. Mayville Engineering has a market cap of $200.17 million and its shares were traded around $10.14. The company has a price-earnings ratio of 18.78 and a price-sales ratio of 0.59.
Mayville Engineering announced its second-quarter results with revenue of $145.13 million and gross profit of $20.54 million, while the net loss was $15.28 million. The 2018 total revenue was $354.53 million, a 13% increase from 2017. The gross profit was $50.58 million, a 46% increase from the year prior. The net loss was $17.94 million.
Chairman, President and CEO Robert D. Kamphuis bought 20,000 shares for $8.79 per share on Oct. 30. Since then, the share price has increased by 15.36%.
Director Timothy L. Christen bought 12,500 shares for $8.94 per share on Oct. 30. Since then, the stock has increased 13.42%.
Verb Technology CFO bought 1,500 shares
CFO Jeff Clayborne bought 1,500 shares for $1.05 per share on Oct. 22. Since then, the share price has decreased by 1.9%. Verb Technology has a market cap of $23.960 million and its shares were traded around $1.03. The company has a price-sales ratio of 5.84.
Verb Technology announced its second-quarter results with revenue of $3.73 million and gross profit of $1.69 million, while the net loss was $2.34 million. The 2018 total revenue was $32,000, a 433% increase from 2017, while the 2018 gross loss was $20,000. The 2018 net loss was $12.13 million.
CEO Rory J. Cutaia bought 1,500 shares for $1.17 per share on Oct. 4. Since then, the stock has declined 11.97%. Director Kenneth S. Cragun bought 1,500 shares for $1.01 per share on Oct. 29. Since then, the stock price has increased by 1.98%. Director Phillip J. Bond bought 1,500 shares for $1.06 per share on Oct. 17. Since then, the stock price has decreased by 2.83%.
TFF Pharmaceuticals CFO bought 1,000 shares
CFO, Secretary and Treasurer Kirk Allen Coleman bought 1,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. TFF Pharmaceuticals has a market cap of $90.020 million and its shares were traded around $5.05.
President and CEO Glenn R. Mattes bought 10,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. Chief Science Officer James Brian Windsor bought 5,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%. Director Harlan F. Weisman bought 5,000 shares for $5 per share on Oct. 25. Since then, the stock price has increased by 1%.
Disclosure: None.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
